Company Overview

Country Condos Limited is an Indian company primarily engaged in the real estate business. The company focuses on developing and selling residential layouts, constructing compound walls, and undertaking the construction and sale of condominiums. Incorporated in 1987 and headquartered in Hyderabad, India, Country Condos Ltd. operates broadly within the real estate sector. Its operations include procuring land banks across the country, developing them into residential layouts complete with amenities such as clubhouses, and selling these plots to customers. The company also undertakes related construction activities for compound walls and other structures within its developed layouts.

Historical Background and Evolution

Country Condos Limited has a history tracing back to a Partnership Firm initially named 'Indocure Therapeutics Limited'. In December 1985, it acquired Pam Industries, a company in distress. The company was officially incorporated as a Private Limited Company under the name 'Neocure Therapeutics Private Limited' on September 25, 1987, in Andhra Pradesh, taking over the partnership firm. It transitioned to a Public Limited Company on August 22, 1988. The company was formerly known as Neocure Therapeutics Ltd. and underwent a significant name change to Country Condos' Limited in December 2006. This rebranding coincided with a strategic diversification into the booming real estate business, particularly in Hyderabad, marking a new phase of operations for the company.

Business Operations and Strategy

The core real estate operations of Country Condos Ltd. involve the acquisition of land parcels across India, their transformation into residential layouts equipped with essential amenities like clubhouses, and the subsequent sale of these plots to customers. Complementing these development activities, the company also engages in the construction of compound walls and other related infrastructure within the developed layouts. Furthermore, Country Condos Ltd. is actively involved in the construction and sale of condominiums. This diversified approach allows the company to capitalize on the growing demand for residential properties in India, with a strategic focus on the Hyderabad region where it holds its headquarters. The company's transition from pharmaceutical manufacturing to real estate development underscores its adaptability and strategic positioning within India's dynamic property market.

Market Performance and Valuation

Country Condos Ltd. is classified as a Small Cap company. As of May 30, 2025, its market capitalization was approximately ₹59 Crore, with figures around ₹65.03 Crore reported on May 16, 2025, and ₹70.5 Crore in another recent assessment, indicating some variation. The stock has demonstrated positive performance; over the last three years, Country Condos Ltd. has delivered a return of 20.75%. More recent data shows a significant uptick, with a 33.65% increase in share price over the past six months and a 33.02% rise in the last year.

Key Financial Metrics (FY2025)

- Revenue & Profitability:

- Revenue: ₹20.0 Crore

- Profit: ₹0.55 Crore

- TTM (Trailing Twelve Months) Profit After Tax: ₹1 Crore

- Valuation Ratios (as on May 30, 2025):

- P/B Ratio: 2.34 times (33% discount to peers' median of 3.50 times)

- P/E Ratio: 104.85 times (117% premium to peers' median of 48.32 times)

- Stock P/E: 128

- Book Value: ₹3.20

- Other Financial Highlights:

- Return on Capital Employed (ROCE): 6.47%

- Return on Equity (ROE): 4.39%

- The company is almost debt-free.

- Despite reporting consistent profits, the company has not paid dividends.

Shareholding Pattern

- Promoter Holding: 53.9% (As of March 2025). Promoter holding has remained stable, with a slight increase from 53.86% in June 2024 to 53.86% in March 2025. There is no promoter pledging reported for Country Condos Ltd.

Stock Exchange Listings

- BSE: 531624

- NSE: COUNCODOS

- ISIN: INE695B01025

The company's equity shares are listed and traded on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) under the trading symbol COUNCODOS.

Recent Developments

The company has recently been the subject of scrutiny from the stock exchange. On April 25, 2025, the Exchange sought clarification from Country Condos Ltd. with reference to significant movements in trading volume and price. This indicates heightened market activity and increased regulatory attention towards the stock's performance.

Country Condos Ltd. represents a notable transformation from its pharmaceutical origins to a dedicated real estate developer. Positioned within India's growing real estate sector, the company focuses on residential layouts and condominiums, particularly targeting the southern Indian market.